tirzepatide vs semaglutide weight loss trials semaglutide: A new battle in obesity treatment VisualAbstract: Tirzepatide Superior to Semaglutide

What was studied: Cardiovascular death and worsening of heart failure over a median follow-up of roughly two years Outcome: Tirzepatide reduced the combined risk of cardiovascular death and worsening heart failure events by approximately 38%, driven largely by a 46% reduction in worsening heart failure events requiring hospitalization or urgent care

A triple agonist is a single molecule designed to bind to and activate three distinct cellular receptors simultaneously

Moreover, the safety profiles of both medications have been extensively studied, revealing that while they may cause gastrointestinal side effects, these are often mild and transient

For researchers and individuals working with compounded formulations, the 5mg lyophilized vial is the standard starting point